RAYDIAX secures €3.5 million in fresh capital to develop its therapy assistance computed tomography system in the fight against cancer
Summary
In addition, RAYDIAX receives public funding from the German Federal Ministry for Economic Affairs and Climate Action (BMWK) RAYDIAX is aiming to significantly expand the use of minimally invasive therapies with the launch of the therapy assistance CT "TACT", addressing demographically driven challenges in healthcare Minimally invasive therapies in many cases offer the potential to deliver cancer treatments on an outpatient basis rather than an inpatient setting; with this increase in the number of outpatient cases the burden on hospital structures is relieved.RAYDIAX, a spin-off of the STIMULATE research campus/ Otto-vonGuericke-University Magdeburg, is developing an image assistance system based on the principles of computed tomography for use in minimally invasive cancer treatments. In addition, RAYDIAX will receive 1.1 million in funding through a top-up of an EXIST: transfer of research grant from the German Federal Ministry for Economic Affairs and Climate Action (BMWK).Dr. With our targeted image-assistance system TACT, we are unleashing a completely new potential that will significantly expand the range of applications of these very gentle interventions, benefiting in particular patients for whom surgical cancer treatment appears to be too risky. Due to the low degree of injury, patients can recover more quickly, hospital stay times are significantly shortened, thus saving costs, and additional treatment capacity is created.The particular challenge with this form of therapy is to place the instruments with sub-millimeter accuracy in a pre-planned surgical area so that the energy input can be targeted in the tumor. "Philipp Kopp, Investment Manager at bmp ventures: "As a deep-tech investor, we were particularly impressed by the profound scientific basis of RAYDIAXs approach and the outstanding technical expertise of the founding team.
Funding
Review available funding amount, funding date, investors, and linked company information related to RAYDIAX secures €3.5 million in fresh capital to develop its therapy assistance computed tomography system in the fight against cancer in the interactive ISVWorld profile.